B. Riley FBR, a preeminent U.S. based investment bank has partnered with TPP Healthcare and the Chinese Pharmaceutical Enterprise Association (CPEA), the leading association of healthcare companies with 3,000+ members, to bring you the largest gathering of healthcare centric companies and investors to date. March 15-17 2018, we will be hosting 100 Western healthcare […]
Category: Investor Relations
Success: China Healthcare Investment & Partnering Symposium 2018
This March, B. Riley FBR, a preeminent U.S. based investment bank, partnered with TPP Healthcare and the Chinese Pharmaceutical Enterprise Association (CPEA), the leading association of healthcare companies with 3,000+ members, to bring the largest gathering of healthcare centric companies and investors to date. March 15-17 2018, we hosted 100+ Western healthcare companies specializing in […]
TPP Healthcare to Offer 1:1 Meeting Space during JP Morgan and Biotech Showcase Healthcare Week in San Francisco – January 8-10, 2018
TPP Healthcare, a strategic advisory firm specializing in cross-border transactions between US, Europe and China’s healthcare companies, in partnership with B. Riley FBR, Inc. and Citigate Dewe Rogerson Life Sciences, will be offering complimentary 1:1 meeting space to during the JP Morgan Healthcare Week for in invited on-site innovators and notable Asian healthcare investors from […]
TPP Healthcare Launches New Website to Provide Stronger Insight to the World of Cross-Border Trade
TPP Healthcare, a strategic advisory firm specializing in cross-border transactions between Western and Chinese healthcare companies, announces its launch of www.tpphealthcare.com – a direct market access strategy site. On the site, current and prospective clients will find useful information about the global healthcare industry, TPP’s services and recent company production numbers. Additionally, viewers will gain valuable insight […]
Save the Date! TPP Healthcare China Partnering Forum 2018
Please mark your calendars for the annual TPP Healthcare China Partnering Forum on January 8-10, 2018 at Parc 55 in San Francisco. This one-of-a-kind event takes place in conjunction with Biotech Showcase during the JP Morgan Healthcare Conference. This unique event offers a designated meeting location for one-on-one networking opportunities with executive level delegates representing […]
TPP Healthcare to Offer 1:1 Meeting Space at JP Morgan and Biotech Showcase Healthcare Week
TPP Healthcare, a strategic advisory firm specializing in cross-border transactions between US, Europe and China’s healthcare companies, in partnership with B. Riley FBR, Inc. and Citigate Dewe Rogerson Life Sciences, will be offering complimentary 1:1 meeting space to during the JP Morgan Healthcare Week for in invited on-site innovators and notable Asian healthcare investors from […]
Industry Headlines I Care About…
News Round Up! My Communications Team recently flagged some articles I thought I’d share. Outside of the CFDA publishing a draft Decision for Adjusting the Administrative Regime for Import Drug Registrations, there is a lot of movement in the cross-border healthcare front… The Wall Street Journal: China Emerges as Powerhouse for Biotech Drugs Drugs are classified into two major categories based […]
My Time at CPEA
Today I had the honor of speaking at the annual Chinese Pharmaceutical Enterprises Association (CPEA) Meeting. Key talking points were: Why is China relevant to my NA/EU clients: The importance of the Chinese healthcare market and Chinese capital to the outside world. Why Chinese should invest in these overseas markets: I stressed the real opportunity […]
In the News…
News Round Up! FierceBiotech: Donald Trump’s First 100 Days, and beyond, for BiopharmaThe article looks at what the next four years could mean for the biopharma industry through Trump’s picks for healthcare top jobs and the power his policies will have over regulatory terms and drug pricing. BioSpectrum Asia: China Will Continue to Rise as a Key Base […]
The Pharma Partners (“TPP”) Announces Agreement to Raise $30M on Behalf of Four US Healthcare and Life Sciences Companies
The Pharma Partners (“TPP”) Announces Agreement to Raise $30M on Behalf of Four US Healthcare and Life Sciences Companies NEW YORK, NY–(Marketwired – June 11, 2015) – The Pharma Partners (“TPP”) today announced an agreement with serial MedTech innovator Amir Belson, MD to raise a total of $30M from Chinese investors to reach four established […]